Home  »  Finance   »  The Chemours Company (CC): Worth A Small Bite At $...

The Chemours Company (CC): Worth A Small Bite At $27.35

The Chemours Company (NYSE:CC) at last check was buoying at $27.35 on Thursday, September 22, with a fall of -2.81% from its closing price on previous day.

Taking a look at stock we notice that its last check on previous day was $28.14 and 5Y monthly beta was reading 1.81 with its price kept floating in the range of $28.10 and $29.98 on the day. Company’s P/E ratio for the trailing 12 months is 5.26. Considering stock’s 52-week price range provides that CC hit a high price of $44.95 and saw its price falling to a low level of $22.56 during that period. Over a period of past 1-month, stock came subtracting -21.37% in its value.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now.

Sponsored

With its current market valuation of $4.69 billion, The Chemours Company is set to declare its quarterly results on Oct 25, 2022. CC Stock’s Forward Dividend of 1.00 and its yield of 3.55% are making investors’ thoughts stronger that it could climb further before the company announces its earnings for the current quarter. Analysts are in estimates of $1.26 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to $5.57 for 2022 with estimates of that growing to $5.83 in next year. These estimates are suggesting current year growth of 39.30% for EPS and 4.70% growth next year.

Analysts watching the company’s growth closely have provided estimates for its revenue growth with an average revenue estimate of $1.69 billion. They suggested that in the process company could generate revenue of as low as $1.46 billion which could climb up to $1.78 billion to hit a high. The average estimate is representing an increase of 6.90% in sales growth from that of posted by the company in the same quarter of last year. In keeping analyst consensus estimate with, company is forecasted to be making an annual revenue of $7.02 billion in 2022, which will be 10.60% more from revenue generated by the company last year.

In last 7 days, analysts came adjusting their opinions about stock’s EPS with no upward and no downward revisions, an indication which could give clearer idea about the company’s short term price movement. In contrast, when we review CC stock’s current outlook then short term indicators are assigning it an average of 100% Sell, while medium term indicators are categorizing the stock at an average of Hold. Long term indicators are suggesting an average of 50% Sell for it.

Digging deeper we become aware of the PEG ratio of the CC stock which is currently positioned at 0.36. It further provides that stock’s current price level is -19.47% away from its 20-day simple moving average and is -20.53% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 27.28 while volatility remained at 5.91% over the past week which changes to 3.96% when measuring it over the past month. Beta is valued at 1.80, while measure of average true range or ATR is currently at 1.60.

In comparing The Chemours Company (CC)’s stock with other industry players reveals that stock’s latest price change of -2.81% and that of 4.18% over the past 12 months is in competing position with that of Honeywell International Inc. (HON) which saw its stock price fall by -0.52% in the recent trading and went through a decrease of -18.89% in past 12-month trading. Industry’s another major player 3M Company (MMM) has fall -0.28% down in latest trading session, but over the past year has faced afall of -35.65% over the same period. The Chemours Company has a P/E ratio of 5.26 against that of Honeywell International Inc.’s 23.77 while 3M Company is showing 16.06 for the same. On the other hand, the S&P 500 Index is down -0.75% in the early deals today while the Dow Jones Industrial was dealinglower at -0.26%.

Having a second look at The Chemours Company (NYSE:CC) provides that stock’s average daily trading volume for 3 months was 1.33 million, while it jumped to 1.67 million when we calculate an average volume for past 10 days. Number of outstanding shares of the stock stood at 156.22 million.

The percentage of outstanding shares held by the insiders is 0.70% while it is 75.00% for the institutional holders. The figures also indicate that as of Aug 30, 2022, number of stock’s short shares was 3.82 million which implies a short ratio of 3.81. This shows down a 2.46% of Short Interest in company’s outstanding shares on the day. In August the standing of shares short improved as it was 4.67 million in the previous month. Subtraction of -16.15% by stock’s current price to its year-to-date value in today’s trading is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.

Leave a Comment

Your email address will not be published.

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]